Literature DB >> 1941141

Inadequate exercise leads to suboptimal imaging. Thallium-201 myocardial perfusion imaging after dipyridamole combined with low-level exercise unmasks ischemia in symptomatic patients with non-diagnostic thallium-201 scans who exercise submaximally.

J F Verzijlbergen1, P H Vermeersch, G J Laarman, C A Ascoop.   

Abstract

This study was undertaken to establish the additional value of 201TI imaging after dipyridamole in combination with low-level exercise in 15 symptomatic patients with non-diagnostic 201TI scans, who exercised submaximally. Most patients had angina, ST-segment depression and even exertional hypotension and were referred for stress 201TI testing for determining the functional significance of known coronary artery disease. Six patients with a normal exercise 201TI test and one patient with an apical defect only were found to have 37 segments (of 105 segments) with reversible perfusion defects after dipyridamole infusion. One patient showing two reversible defects after exercise had five reversible segments after dipyridamole. Seven patients with fixed defects in 28 segments after exercise and two with small areas of border zone ischemia in seven additional (sub)segments, demonstrated fixed in defects in only nine segments but reversible defects in 40 segments after dipyridamole. Quantitative analysis resulted in 24.8 +/- 28.5 (mean value) sample points below -2 s.d. of the mean normal uptake after exercise, which increased to 72 +/- 26.5 after dipyridamole infusion (p less than 0.005). The washout analysis resulted in a mean value of 5.5 +/- 8.1 sample points below -2 s.d. after exercise, increasing to 33.3 +/- 22.1 after dipyridamole (p less than 0.005). Thallium-201 myocardial perfusion imaging after dipyridamole combined with low-level upright bicycle exercise may unmask scintigraphic evidence for ischemia in symptomatic patients who would otherwise have non-diagnostic imaging studies during submaximal exercise.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1941141

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  21 in total

Review 1.  Clinical considerations in cardiac stress testing.

Authors:  K A Latus; S R Underwood
Journal:  J Nucl Cardiol       Date:  2001 May-Jun       Impact factor: 5.952

2.  Safety and feasibility of atropine added to submaximal exercise stress testing with Tl-201 SPECT for the diagnosis of myocardial ischemia.

Authors:  Sanjay K Prasad; Dudley J Pennell
Journal:  J Nucl Cardiol       Date:  2002 Nov-Dec       Impact factor: 5.952

3.  Procedure guidelines for radionuclide myocardial perfusion imaging.

Authors:  C Anagnostopoulos; M Harbinson; A Kelion; K Kundley; C Y Loong; A Notghi; E Reyes; W Tindale; S R Underwood
Journal:  Heart       Date:  2004-01       Impact factor: 5.994

4.  Symptom-limited exercise combined with dipyridamole stress: prognostic value in assessment of known or suspected coronary artery disease by use of gated SPECT imaging.

Authors:  Alan W Ahlberg; Sarkis B Baghdasarian; Haris Athar; Jeffrey P Thompsen; Deborah M Katten; Gavin L Noble; Igor Mamkin; Anuj R Shah; Ivette A Leka; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2008 Jan-Feb       Impact factor: 5.952

5.  Comparison of technetium-99m sestamibi left ventricular wall motion and perfusion studies with thallium-201 perfusion imaging: in search of the combination of variables with the highest accuracy in predicting coronary artery disease.

Authors:  J F Verzijlbergen; A H Zwinderman; C A Ascoop; E E van der Wall; M G Niemeyer; E K Pauwels
Journal:  Eur J Nucl Med       Date:  1996-05

6.  Influence of cardiac stress protocol on myocardial perfusion imaging accuracy: The role of exercise level on the evaluation of ischemic burden.

Authors:  Alessia Gimelli; Riccardo Liga; Emilio Maria Pasanisi; Mirta Casagranda; Michele Coceani; Paolo Marzullo
Journal:  J Nucl Cardiol       Date:  2015-03-27       Impact factor: 5.952

7.  A strategy of symptom-limited exercise with regadenoson-as-needed for stress myocardial perfusion imaging: a randomized controlled trial.

Authors:  Matthew W Parker; Donna Chelle Morales; Hanna B Slim; Alan W Ahlberg; Deborah M Katten; Giselle Cyr; Shishir Mathur; Afrooz Ardestani; Dimitrios Barmpouletos; Geeta Swamy Iyah; Steven M Borer; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2012-11-28       Impact factor: 5.952

8.  Exercise supplementation to dipyridamole prevents hypotension, improves electrocardiogram sensitivity, and increases heart-to-liver activity ratio on Tc-99m sestamibi imaging.

Authors:  J V Vitola; J C Brambatti; F Caligaris; C R Lesse; P R Nogueira; A I Joaquim; M Loyo; F V Salis; E V Paiva; W A Chalela; J C Meneghetti
Journal:  J Nucl Cardiol       Date:  2001 Nov-Dec       Impact factor: 5.952

9.  H-FABP, cardiovascular risk factors, and functional status in asymptomatic spinal cord injury patients.

Authors:  A Akbal; A Kurtaran; B Selçuk; M Akyüz
Journal:  Herz       Date:  2013-03-14       Impact factor: 1.443

10.  Safety and tolerability of regadenoson in 514 SPECT MPI patients with and without coronary artery disease and submaximal exercise heart rate response.

Authors:  Wael A AlJaroudi; M C Alraies; Manuel D Cerquiera; Wael A Jaber
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-12-04       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.